Effect of Dietary DHA Supplementation on Sperm Quality
1 other identifier
interventional
120
1 country
1
Brief Summary
The aim of this study is evaluated the effect of dietetic supplementation with DHA on human sperm quality, antioxidant capacity and sperm DNA damage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 7, 2011
CompletedFirst Posted
Study publicly available on registry
June 8, 2011
CompletedJune 8, 2011
June 1, 2011
1 year
June 7, 2011
June 7, 2011
Conditions
Outcome Measures
Primary Outcomes (6)
sperm concentration
million of spermatozoa per milimitre
5 weeks
Sperm motility
Percentage of motile sperm.
5 weeks
Sperm morphology
Percentage of sperm with normal morphology
5 weeks
Total capacity antioxidant
Total antioxidant capacity (TAC)is a colorimetric assay that measure the combined antioxidant activities of all its non enzymatic constituents in seminal plasma.
5 weeks
Sperm DNA damage.
DNA fragmentation analysis was evaluated by TUNEL test and measured by flow cytometry
5 weeks
Fatty acids measure.
Fatty acid analysis in seminal plasma and spermatozoa were evaluated by gas chromatography.The percentage of each fatty acid class was expressed as percentage of total fatty acids.
5 weeks
Secondary Outcomes (3)
Sperm in ejaculate
5 weeks
Volume of ejaculate.
5 weeks
Sperm viability
5 weeks
Study Arms (2)
Sunflower oil
PLACEBO COMPARATORDocosahexanoic acid
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Diagnosis of male factor.
You may not qualify if:
- Metabolic and genetic diseases.
- Oncological patients.
- Patients with anticoagulants treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Valenciano de infertilidad
Murcia, Murcia, 30007, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martinez Soto, Juan Carlos
IVI Murcia
- STUDY DIRECTOR
Landeras Gutierrez, Jose
IVI Murcia
- STUDY CHAIR
Nicolas Arnau, Maria
IVI Murcia
- STUDY CHAIR
Fernandez Olmedilla, Laura
IVI Murcia
- STUDY CHAIR
Albero Pilar
IVI Murcia
- STUDY CHAIR
Domingo JC
University of Barcelona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 7, 2011
First Posted
June 8, 2011
Study Start
December 1, 2009
Primary Completion
December 1, 2010
Study Completion
March 1, 2011
Last Updated
June 8, 2011
Record last verified: 2011-06